Rocket One Inc. has regained full compliance with Nasdaq’s minimum bid price requirement for its RKTO common stock. Nasdaq notified the company that, for the ten consecutive business days from June 9 through June 23, 2026, Rocket One’s closing bid price stayed at or above $1.00 per share, satisfying Listing Rule 5550(a)(2). As a result, the company’s continued listing on The Nasdaq Capital Market is no longer at risk from this issue. Management links this milestone to its ongoing strategic shift from biotechnology to advanced AI computing, defense infrastructure, and space-enabling technologies.
Rocket One Inc., formerly Hoth Therapeutics, has amended its Nevada charter to change its corporate name to Rocket One Inc. effective May 26, 2026. The company’s common stock will begin trading on The Nasdaq Capital Market under the new ticker “RKTO” on May 28, 2026, replacing “HOTH.”
The company is repositioning around the “orbital economy,” focusing on next-generation nanomagnetic AI chip technology designed for ultra-low-power, radiation-tolerant computing in space and defense applications. Its legacy biotechnology programs will continue under a wholly owned subsidiary, now named Rocket One.0 Inc. Shareholder rights and the CUSIP for the common stock remain unchanged.